T1	AdverseReaction 53 74	Thyroid C-cell Tumors
T2	AdverseReaction 111 123	Pancreatitis
T3	AdverseReaction 355 367	Hypoglycemia
T4	AdverseReaction 566 582	Hypersensitivity
T5	AdverseReaction 728 744	Renal Impairment
T6	Animal 1118 1122	rats
T7	AdverseReaction 1220 1241	thyroid C-cell tumors
T8	AdverseReaction 1220 1234;1243 1251	thyroid C-cell adenomas
T9	AdverseReaction 1220 1234;1256 1266	thyroid C-cell carcinomas
T10	AdverseReaction 1396 1419	thyroid C-cell adenomas
T11	AdverseReaction 1396 1410;1424 1434	thyroid C-cell carcinomas
T12	Animal 1438 1442	mice
T13	AdverseReaction 1529 1550	thyroid C-cell tumors
T14	AdverseReaction 1562 1589	medullary thyroid carcinoma
T15	AdverseReaction 1591 1594	MTC
T16	Animal 1654 1660	rodent
T17	AdverseReaction 1661 1682	thyroid C-cell tumors
T18	AdverseReaction 1727 1730	MTC
T19	AdverseReaction 1893 1896	MTC
T20	DrugClass 1943 1965	GLP-1 receptor agonist
T21	AdverseReaction 2112 2115	MTC
T22	AdverseReaction 3242 3254	pancreatitis
T23	AdverseReaction 3465 3477	pancreatitis
T24	AdverseReaction 4161 4173	hypoglycemia
T25	AdverseReaction 4478 4503	Systemic hypersensitivity
T26	AdverseReaction 4853 4872	acute renal failure
T27	AdverseReaction 4890 4911	chronic renal failure
T28	DrugClass 4787 4810	GLP-1 receptor agonists
T29	AdverseReaction 5113 5119	nausea
T30	AdverseReaction 5121 5129	vomiting
T31	AdverseReaction 5131 5139	diarrhea
T32	AdverseReaction 5144 5155	dehydration
T33	AdverseReaction 5585 5619	gastrointestinal adverse reactions
T34	Severity 5631 5637	severe
T35	Animal 1447 1451	rats
T36	Factor 4153 4157	risk
T37	Factor 1492 1499	unknown
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	Animal:T6
E7	AdverseReaction:T7 Hypothetical:E6
E8	AdverseReaction:T8 Hypothetical:E6
E9	AdverseReaction:T9 Hypothetical:E6
E10	AdverseReaction:T10 Hypothetical:E12
E11	AdverseReaction:T11 Hypothetical:E12 Hypothetical2:E36 Hypothetical3:E36
E12	Animal:T12
E13	AdverseReaction:T13 Hypothetical:E16 Hypothetical2:E38
E14	AdverseReaction:T14 Hypothetical:E16 Hypothetical2:E38
E15	AdverseReaction:T15 Hypothetical:E16 Hypothetical2:E38
E16	Animal:T16
E17	AdverseReaction:T17 Hypothetical:E16
E18	AdverseReaction:T18
E19	AdverseReaction:T19 Hypothetical:E20
E20	DrugClass:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23
E24	AdverseReaction:T24 Hypothetical:E37
E25	AdverseReaction:T25
E26	AdverseReaction:T26 Hypothetical:E28
E27	AdverseReaction:T27 Hypothetical:E28
E28	DrugClass:T28
E29	AdverseReaction:T29
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T33 Effect:E35
E35	Severity:T34
E36	Animal:T35
E37	Factor:T36
E38	Factor:T37
A1	flag E1 duplicate
A2	CUI E1 C0342190
A3	UMLS-Preferred-Name E1 C-cell hyperplasia of thyroid
A4	MEDDRA-PT E1 Thyroid C-cell hyperplasia
A5	MEDDRA-PT-ID E1 10070568
A6	CUI E2 C0030305
A7	UMLS-Preferred-Name E2 Pancreatitis
A8	MEDDRA-PT E2 Pancreatitis
A9	MEDDRA-PT-ID E2 10033645
A10	CUI E3 C0020615
A11	UMLS-Preferred-Name E3 Hypoglycemia
A12	MEDDRA-PT E3 Hypoglycaemia
A13	MEDDRA-PT-ID E3 10020993
A14	LLT E3 Hypoglycemia
A15	LLT-ID E3 10021005
A16	CUI E4 C0020517
A17	UMLS-Preferred-Name E4 Hypersensitivity
A18	MEDDRA-PT E4 Hypersensitivity
A19	MEDDRA-PT-ID E4 10020751
A20	CUI E5 C1565489
A21	UMLS-Preferred-Name E5 Renal Insufficiency
A22	MEDDRA-PT E5 Renal impairment
A23	MEDDRA-PT-ID E5 10062237
A24	flag E7 duplicate
A25	CUI E7 C0342190
A26	UMLS-Preferred-Name E7 C-cell hyperplasia of thyroid
A27	MEDDRA-PT E7 Thyroid C-cell hyperplasia
A28	MEDDRA-PT-ID E7 10070568
A29	flag E8 duplicate
A30	CUI E8 C0342190
A31	UMLS-Preferred-Name E8 C-cell hyperplasia of thyroid
A32	MEDDRA-PT E8 Thyroid C-cell hyperplasia
A33	MEDDRA-PT-ID E8 10070568
A34	flag E9 duplicate
A35	CUI E9 C0549473
A36	UMLS-Preferred-Name E9 Thyroid carcinoma
A37	MEDDRA-PT E9 Thyroid cancer
A38	MEDDRA-PT-ID E9 10066474
A39	LLT E9 Thyroid carcinoma
A40	LLT-ID E9 10043702
A41	flag E10 duplicate
A42	CUI E10 C0342190
A43	UMLS-Preferred-Name E10 C-cell hyperplasia of thyroid
A44	MEDDRA-PT E10 Thyroid C-cell hyperplasia
A45	MEDDRA-PT-ID E10 10070568
A46	flag E11 duplicate
A47	CUI E11 C0549473
A48	UMLS-Preferred-Name E11 Thyroid carcinoma
A49	MEDDRA-PT E11 Thyroid cancer
A50	MEDDRA-PT-ID E11 10066474
A51	LLT E11 Thyroid carcinoma
A52	LLT-ID E11 10043702
A53	flag E13 duplicate
A54	CUI E13 C0342190
A55	UMLS-Preferred-Name E13 C-cell hyperplasia of thyroid
A56	MEDDRA-PT E13 Thyroid C-cell hyperplasia
A57	MEDDRA-PT-ID E13 10070568
A58	CUI E14 C0238462
A59	UMLS-Preferred-Name E14 Medullary carcinoma of thyroid
A60	MEDDRA-PT E14 Medullary thyroid cancer
A61	MEDDRA-PT-ID E14 10027105
A62	LLT E14 Medullary carcinoma of thyroid
A63	LLT-ID E14 10027101
A64	CUI E15 C0238462
A65	UMLS-Preferred-Name E15 Medullary carcinoma of thyroid
A66	MEDDRA-PT E15 Medullary thyroid cancer
A67	MEDDRA-PT-ID E15 10027105
A68	LLT E15 Medullary carcinoma of thyroid
A69	LLT-ID E15 10027101
A70	flag E17 duplicate
A71	CUI E17 C0342190
A72	UMLS-Preferred-Name E17 C-cell hyperplasia of thyroid
A73	MEDDRA-PT E17 Thyroid C-cell hyperplasia
A74	MEDDRA-PT-ID E17 10070568
A75	CUI E18 C0238462
A76	UMLS-Preferred-Name E18 Medullary carcinoma of thyroid
A77	MEDDRA-PT E18 Medullary thyroid cancer
A78	MEDDRA-PT-ID E18 10027105
A79	LLT E18 Medullary carcinoma of thyroid
A80	LLT-ID E18 10027101
A81	CUI E19 C0238462
A82	UMLS-Preferred-Name E19 Medullary carcinoma of thyroid
A83	MEDDRA-PT E19 Medullary thyroid cancer
A84	MEDDRA-PT-ID E19 10027105
A85	LLT E19 Medullary carcinoma of thyroid
A86	LLT-ID E19 10027101
A87	CUI E21 C0238462
A88	UMLS-Preferred-Name E21 Medullary carcinoma of thyroid
A89	MEDDRA-PT E21 Medullary thyroid cancer
A90	MEDDRA-PT-ID E21 10027105
A91	LLT E21 Medullary carcinoma of thyroid
A92	LLT-ID E21 10027101
A93	CUI E22 C0030305
A94	UMLS-Preferred-Name E22 Pancreatitis
A95	MEDDRA-PT E22 Pancreatitis
A96	MEDDRA-PT-ID E22 10033645
A97	CUI E23 C0030305
A98	UMLS-Preferred-Name E23 Pancreatitis
A99	MEDDRA-PT E23 Pancreatitis
A100	MEDDRA-PT-ID E23 10033645
A101	CUI E24 C0020615
A102	UMLS-Preferred-Name E24 Hypoglycemia
A103	MEDDRA-PT E24 Hypoglycaemia
A104	MEDDRA-PT-ID E24 10020993
A105	LLT E24 Hypoglycemia
A106	LLT-ID E24 10021005
A107	CUI E25 C1736167
A108	UMLS-Preferred-Name E25 Systemic allergic reaction
A109	MEDDRA-PT E25 Hypersensitivity
A110	MEDDRA-PT-ID E25 10020751
A111	LLT E25 Systemic allergic reaction
A112	LLT-ID E25 10066472
A113	CUI E26 C0022660
A114	UMLS-Preferred-Name E26 Kidney Failure, Acute
A115	MEDDRA-PT E26 Acute kidney injury
A116	MEDDRA-PT-ID E26 10069339
A117	LLT E26 Acute renal failure
A118	LLT-ID E26 10001041
A119	CUI E27 C0022661
A120	UMLS-Preferred-Name E27 Kidney Failure, Chronic
A121	MEDDRA-PT E27 Chronic kidney disease
A122	MEDDRA-PT-ID E27 10064848
A123	LLT E27 Chronic renal failure
A124	LLT-ID E27 10009119
A125	CUI E29 C0027497
A126	UMLS-Preferred-Name E29 Nausea
A127	MEDDRA-PT E29 Nausea
A128	MEDDRA-PT-ID E29 10028813
A129	CUI E30 C0042963
A130	UMLS-Preferred-Name E30 Vomiting
A131	MEDDRA-PT E30 Vomiting
A132	MEDDRA-PT-ID E30 10047700
A133	CUI E31 C0011991
A134	UMLS-Preferred-Name E31 Diarrhea
A135	MEDDRA-PT E31 Diarrhoea
A136	MEDDRA-PT-ID E31 10012735
A137	LLT E31 Diarrhea
A138	LLT-ID E31 10012727
A139	CUI E32 C0011175
A140	UMLS-Preferred-Name E32 Dehydration
A141	MEDDRA-PT E32 Dehydration
A142	MEDDRA-PT-ID E32 10012174
A143	CUI E33 C0426576
A144	UMLS-Preferred-Name E33 Gastrointestinal symptom
A145	MEDDRA-PT E33 Gastrointestinal disorder
A146	MEDDRA-PT-ID E33 10017944
A147	LLT E33 Gastrointestinal symptom NOS
A148	LLT-ID E33 10018011
